Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$15.00 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships: Workshop Summary Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary Other Related Titles Future Opportunities to Leverage the Alzheimer's Disease Neuroimaging Initiative: Workshop Summary (2010) Board on Health Sciences Policy (HSP) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix A: References." Future Opportunities to Leverage the Alzheimer's Disease Neuroimaging Initiative: Workshop Summary. Washington, DC: The National Academies Press, 2010. Please select a format: Page 19   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix A References Brookmeyer, R., E. Johnson, K. Ziegler-Graham, and H. M. Arrighi. 2007. Forecasting the global burden of Alzheimer’s disease. Alzheimer’s and Dementia 3(3):186–191. Burns, L., G. L’Italien, Z. Guo, P. Lapuerta, R. M. Berman, S. Kaplita, H. Feldman, M. Donohue. 2010. Exploring CSF biomarker cutpoints with penalized spline analysis and maximized log rank test. Alzheimer’s and Dementia 6(4):S508. Dubois, B., H. H. Feldman, C. Jacova, S. T. Dekosky, P. Barberger-Gateau, J. Cummings, A. Delacourte, D. Galasko, S. Gauthier, G. Jicha, K. Meguro, J. O’Brien, F. Pasquier, P. Robert, M. Rossor, S. Salloway, Y. Stern, P. J. Visser, and P. Scheltens. 2007. Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6(8):734–746. Ellis, K. A., A. I. Bush, D. Darby, D. De Fazio, J. Foster, P. Hudson, N. T. Lautenschlager, N. Lenzo, R. N. Martins, P. Maruff, C. Masters, A. Milner, K. Pike, C. Rowe, G. Savage, C. Szoeke, K. Taddei, V. Villemagne, M. Woodward, and D. Ames. 2009. The Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging: Methodology and baseline characteristics of 1,112 individuals recruited for a longitudinal study of Alzheimer’s disease. Int Psychogeriatr 21(4):672–687. Frisoni, G. B., N. C. Fox , C. R. Jack, Jr., P. Scheltens, and P. M. Thompson. 2010. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6(2):67–77. Jack, C. R., Jr., D. S. Knopman, W. J. Jagust, L. M. Shaw, P. S. Aisen, M. W. Weiner, R. C. Petersen, and J. Q. Trojanowski. 2010. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9(1):119–128. Rowe, C. C., K. A. Ellis, M. Rimajova, P. Bourgeat, K. E. Pike, G. Jones, J. Fripp, H. Tochon-Danguy, L. Morandeau, G. O’Keefe, R. Price, P. Raniga, P. Robins, O. Acosta, N. Lenzo, C. Szoeke, O. Salvado, R. Head, R. Martins, C. L. Masters, D. Ames, and V. L. Villemagne. 2010. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging. Neurobiol Aging 31(8):1275–1283. United Nations. 2007. World population prospects: The 2006 revision, highlights. Working Paper No. ESA/P/WP.202. Department of Economic and Social Affairs, Population Division. Page 19 Front Matter (R1-R12) Workshop Summary (1-18) Appendix A: References (19-20) Appendix B: Workshop Agenda (21-24)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 19
Future Opportunities to Leverage the Alzheimer’s Disease Neuroimaging Initiative: Workshop Summary Appendix A References Brookmeyer, R., E. Johnson, K. Ziegler-Graham, and H. M. Arrighi. 2007. Forecasting the global burden of Alzheimer’s disease. Alzheimer’s and Dementia 3(3):186–191. Burns, L., G. L’Italien, Z. Guo, P. Lapuerta, R. M. Berman, S. Kaplita, H. Feldman, M. Donohue. 2010. Exploring CSF biomarker cutpoints with penalized spline analysis and maximized log rank test. Alzheimer’s and Dementia 6(4):S508. Dubois, B., H. H. Feldman, C. Jacova, S. T. Dekosky, P. Barberger-Gateau, J. Cummings, A. Delacourte, D. Galasko, S. Gauthier, G. Jicha, K. Meguro, J. O’Brien, F. Pasquier, P. Robert, M. Rossor, S. Salloway, Y. Stern, P. J. Visser, and P. Scheltens. 2007. Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6(8):734–746. Ellis, K. A., A. I. Bush, D. Darby, D. De Fazio, J. Foster, P. Hudson, N. T. Lautenschlager, N. Lenzo, R. N. Martins, P. Maruff, C. Masters, A. Milner, K. Pike, C. Rowe, G. Savage, C. Szoeke, K. Taddei, V. Villemagne, M. Woodward, and D. Ames. 2009. The Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging: Methodology and baseline characteristics of 1,112 individuals recruited for a longitudinal study of Alzheimer’s disease. Int Psychogeriatr 21(4):672–687. Frisoni, G. B., N. C. Fox , C. R. Jack, Jr., P. Scheltens, and P. M. Thompson. 2010. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6(2):67–77. Jack, C. R., Jr., D. S. Knopman, W. J. Jagust, L. M. Shaw, P. S. Aisen, M. W. Weiner, R. C. Petersen, and J. Q. Trojanowski. 2010. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9(1):119–128. Rowe, C. C., K. A. Ellis, M. Rimajova, P. Bourgeat, K. E. Pike, G. Jones, J. Fripp, H. Tochon-Danguy, L. Morandeau, G. O’Keefe, R. Price, P. Raniga, P. Robins, O. Acosta, N. Lenzo, C. Szoeke, O. Salvado, R. Head, R. Martins, C. L. Masters, D. Ames, and V. L. Villemagne. 2010. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging. Neurobiol Aging 31(8):1275–1283. United Nations. 2007. World population prospects: The 2006 revision, highlights. Working Paper No. ESA/P/WP.202. Department of Economic and Social Affairs, Population Division.

OCR for page 20
Future Opportunities to Leverage the Alzheimer’s Disease Neuroimaging Initiative: Workshop Summary This page intentionally left blank.